VanEck launched the VanEck Biotech ETF (BBH) on Dec. 20, 2011, designed to provide broad exposure to the Healthcare—Biotech equity segment. The article provides background on the ETF’s passive, segment-focused mandate with no stated performance, flows, or policy changes.
VanEck launched the VanEck Biotech ETF (BBH) on Dec. 20, 2011, designed to provide broad exposure to the Healthcare—Biotech equity segment. The article provides background on the ETF’s passive, segment-focused mandate with no stated performance, flows, or policy changes.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.00
